e.g. Tata motors, Reliance MF, 500570

AstraZeneca Pharma India Ltd. - Research Center

506820 ASTRAZEN Group (A) BSE data
 
Back to Company Page
Statement:

Profit loss account

(Rs crore)
Mar ' 24 Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20
Income
Operating income 1,295.53 1,002.97 805.60 813.56 831.81
Expenses
Material consumed 596.77 362.42 315.07 297.98 307.86
Manufacturing expenses 4.87 5.54 8.10 7.37 7.72
Personnel expenses 241.45 259.10 230.21 219.54 216.70
Selling expenses - - - - -
Adminstrative expenses 267.99 210.79 166.04 153.20 178.83
Expenses capitalised - - - - -
Cost of sales 1,111.08 837.85 719.42 678.09 711.11
Operating profit 184.45 165.12 86.18 135.47 120.70
Other recurring income 34.80 26.10 14.76 12.84 12.99
Adjusted PBDIT 219.25 191.22 100.94 148.31 133.69
Financial expenses 1.20 0.63 0.95 1.09 1.14
Depreciation 14.94 16.26 16.95 20.13 18.58
Other write offs - - - - -
Adjusted PBT 203.11 174.33 83.04 127.09 113.97
Tax charges 58.03 34.81 21.44 33.79 41.76
Adjusted PAT 145.08 139.52 61.60 93.30 72.21
Non recurring items 17.43 -42.84 -1.74 3.43 -4.92
Other non cash adjustments - - - - -
Reported net profit 162.51 96.68 59.86 96.73 67.29
Earnigs before appropriation 618.15 475.64 383.96 329.10 235.38
Equity dividend 40.00 20.00 5.00 5.00 1.99
Preference dividend - - - - -
Dividend tax - - - - 0.51
Retained earnings 578.15 455.64 378.96 324.10 232.88
Close
Add AstraZeneca Pharma India Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add AstraZeneca Pharma India Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback